Epion Therapeutics announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to ...
The US Food and Drug Administration (FDA) has selected Abeona Therapeutics’ ABO-503 gene therapy for X-linked retinoschisis ...
Pediatric progressive myopia is a growing global public health concern, linked to serious ocular complications including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback